CYCS and lung cancer: In vitro anti-lung cancer studies revealed that SC, SCA, SCH, and SCAH decreased MMP, decreased Bcl-2 expression, increased the release of cytochrome c, increased activation of caspase-9 and -3, and increased late apoptosis of A-549 cells.